On May 12, 2009, a lawsuit was filed against the U.S. Patent and Trademark Office and Myriad Genetics challenging Myriad’s patent on two genes, BRCA 1 and BRCA2.
DNA analysis has benefited from advances in bioarray technology. Bioarrays are similar to electronic memory, storing known information for comparison to unknown data for identification. They have emerged as the fastest and most efficient DNA analysis technique, giving researchers the ability to perform up to 10,000 DNA tests, and more, at one time on a [...]
You are currently browsing the weblog archives for 'genes' tag.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.
Biotech Trading Signals Pharma News Biotech News